GlassScriptPhysician profile
Peter Samuel Billing
NPI 1801817028
$109,248.85
in general payments reported to CMS, 2019-2025
18 companies · $45K in 2025
The $45K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $5,863 · 2021: $4,808 · 2022: $19K · 2023: $3,708 · 2024: $11K · 2025: $45K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $22K · Consulting Fee: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $5,878 · Travel and Lodging: $3,829 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $22,022.67 |
| Consulting Fee | $15,497.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,790.00 |
| Food and Beverage | $5,877.99 |
| Travel and Lodging | $3,828.59 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $34,043.81 | 2021-2025 | Signia, Ligasure, Sonicision |
| Merit Medical Systems INC | $22,946.84 | 2024-2025 | Tif, Esophyx |
| Reshape Lifesciences INC. | $17,584.97 | 2019-2023 | |
| Intuitive Surgical, INC. | $16,859.91 | 2022-2023 | Da Vinci Surgical System |
| Senseonics, Incorporated | $5,360.00 | 2019-2023 | Eversense |
| Novo Nordisk INC | $3,810.89 | 2021-2025 | Wegovy, Saxenda |
| Covidien LP | $3,600.00 | 2020 | |
| Ethicon US, LLC | $1,575.27 | 2020-2025 | Echelon; Endopath, Echelon Flex |
| Enterra Medical, INC. | $1,387.09 | 2024 | |
| Medical Device Business Services, INC. | $1,300.00 | 2022 | |
| Ascensia Diabetes Care US INC. | $287.22 | 2021 | |
| Apollo Endosurgery US INC | $193.61 | 2019 | |
| Davol INC. | $125.52 | 2022 | |
| Lilly USA, LLC | $71.42 | 2023-2025 | Mounjaro, Zepbound |
| Currax Pharmaceuticals LLC | $40.94 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $38.32 | 2022 | |
| Shire North American Group INC | $18.58 | 2019 | |
| Heron Therapeutics, INC. | $4.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Billing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.